MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation Operating Cash Flow 2011-2026 | DHR
Annual Operating Cash Flow Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.42 B | 6.69 B | 7.16 B | 8.52 B | 8.36 B | 6.21 B | 3.95 B | 4.02 B | 3.48 B | 3.52 B | 3.8 B | 3.76 B | 3.59 B | 3.42 B | 2.63 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.52 B | 2.63 B | 5.03 B |
Quarterly Operating Cash Flow Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.3 B | - | 1.74 B | - | - | - | 1.97 B | - | - | 3.99 B | 1.87 B | - | 3.99 B | 2.26 B | 819 M | - | 2.84 B | 1.87 B | 703 M | - | 2.78 B | 1.86 B | 829 M | - | 2.64 B | 1.57 B | 560 M | - | 2.87 B | 2.05 B | 773 M | - | 2.57 B | 1.62 B | 524 M | - | 2.52 B | 1.5 B | 511 M | - | 2.51 B | 1.54 B | 636 M | - | 2.62 B | 1.65 B | 645 M | - | 1.8 B | 1.1 B | 436 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.99 B | 436 M | 1.76 B |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioNano Genomics
BNGO
|
-16.3 M | $ 1.14 | 0.44 % | $ 6.21 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.07 | 1.39 % | $ 173 M |  China |
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.48 B | $ 115.09 | 0.03 % | $ 35 B | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 16.32 | 1.65 % | $ 870 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 498.22 | 0.95 % | $ 14.4 B | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.45 | 2.3 % | $ 412 M | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 7.87 | 2.34 % | $ 1.01 B | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 1.4 | 2.19 % | $ 1.86 M | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 23.05 | -0.35 % | $ 640 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 6.62 | -0.9 % | $ 276 M | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 176.51 | 0.49 % | $ 8.75 B | USA |
 |
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.58 | -0.1 % | $ 2.67 B | USA |
 |
Neuronetics
STIM
|
-20.4 M | $ 1.37 | 1.11 % | $ 90.4 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
837 M | $ 122.69 | 1.46 % | $ 19.5 B | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 14.96 | 3.67 % | $ 452 M | USA |
 |
Thermo Fisher Scientific
TMO
|
7.82 B | $ 500.25 | 0.83 % | $ 189 B | USA |
 |
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.69 | -3.28 % | $ 61.9 M |  Irlanda |
 |
Guardant Health
GH
|
-185 M | $ 79.27 | 0.85 % | $ 9.94 B | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 48.44 | 1.11 % | $ 2.9 B | USA |
 |
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.73 | 1.49 % | $ 88.6 K | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.1 | -2.1 % | $ 4.82 M | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 107.45 | 0.59 % | $ 8.86 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 261.12 | 0.07 % | $ 21.7 B | USA |
 |
Natera
NTRA
|
-432 M | $ 197.55 | 2.34 % | $ 19.4 B | USA |
 |
Celcuity
CELC
|
-153 M | $ 118.08 | 0.8 % | $ 5.52 B | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 80.41 | -0.23 % | $ 5.43 B | USA |
 |
Waters Corporation
WAT
|
653 M | $ 318.26 | -0.54 % | $ 19 B | USA |